Specific verification of anti‐P53, anti‐MSH2, and anti‐Tm‐4 protein antibodies and levels of P53, MSH2, and Tm‐4 protein in AFP‐Negative HCC and adjacent tissues. This evidence concerns the gene TP53 and hepatocellular carcinoma.